Comments
Drug firm Sun Pharmaceutical Industries today said its board of directors has approved the proposal to raise up to Rs 8,000 crore.
The board has approved raising of funds worth up to Rs 8,000 crore through domestic or international offerings, Sun Pharmaceuticals said in a filing to the BSE.
According to the company, the proposal would be put for shareholders’ approval during the annual general meeting scheduled on November 8.
The funds would be raised at an appropriate time “through domestic/international offerings including to Indian or foreign institutional investors/foreign mutual funds/overseas corporate bodies/foreigners/other foreign parties/Indian financial institutions/alternative investment funds/qualified institutional buyers/companies/individuals...” it said.
Shares of Sun Pharmaceutical Industries today closed at Rs 697.60 per scrip on the BSE, up 0.72 per cent from its previous close.
Comments
COMMENT NOW
Comments
Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.
We have migrated to a new commenting platform. If you are already a registered user of TheHindu Businessline and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.